David Lebwohl - Sep 24, 2021 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
EVP, Chief Medical Officer
Signature
/s/James Basta, Attorney-in-fact
Stock symbol
NTLA
Transactions as of
Sep 24, 2021
Transactions value $
$99,988
Form type
4
Date filed
9/27/2021, 04:15 PM
Previous filing
Sep 23, 2021
Next filing
Oct 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Options Exercise $100K +7.92K +1001.64% $12.62 8.71K Sep 24, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTLA Stock Option (right to buy) Options Exercise $0 -7.92K -4.11% $0.00 185K Sep 24, 2021 Common Stock 7.92K $12.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 66,666 shares as of September 24, 2021.